Pages that link to "Q57060641"
Jump to navigation
Jump to search
The following pages link to Ottavio De Cobelli (Q57060641):
Displaying 50 items.
- Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) (Q21256692) (← links)
- Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches (Q28080936) (← links)
- Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urology. (Q30315523) (← links)
- No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy (Q31083823) (← links)
- Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. (Q33334473) (← links)
- Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance (Q33566981) (← links)
- Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml (Q34825819) (← links)
- Radiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients (Q35511975) (← links)
- Metachronous bladder metastases from renal cell carcinoma: a case report and review of the literature. (Q35602169) (← links)
- The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer. (Q35689822) (← links)
- Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents. (Q35906161) (← links)
- Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study (Q35990762) (← links)
- Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience (Q36207083) (← links)
- Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer. (Q36295691) (← links)
- Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma. (Q36299355) (← links)
- Cancer of the prostate. (Q36323365) (← links)
- Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers. (Q36355609) (← links)
- Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study. (Q36421012) (← links)
- In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. (Q36612195) (← links)
- European Study of Radical Prostatectomy: time trends in Europe, 1993-2005. (Q36861743) (← links)
- Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience (Q37146457) (← links)
- Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis (Q37190399) (← links)
- External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1. (Q37344341) (← links)
- Multidisciplinary approach in the treatment of patients with small cell bladder carcinoma (Q37873634) (← links)
- Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis (Q38118809) (← links)
- Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion. (Q38388976) (← links)
- Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer (Q38588658) (← links)
- Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml (Q38646996) (← links)
- Biomarkers in localized prostate cancer (Q38697114) (← links)
- High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach. (Q38758360) (← links)
- The emerging role of obesity, diet and lipid metabolism in prostate cancer (Q38821546) (← links)
- The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo (Q38865724) (← links)
- Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation? (Q38891639) (← links)
- Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. (Q38905219) (← links)
- The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review. (Q38910154) (← links)
- Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn? (Q38952903) (← links)
- Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy (Q39282130) (← links)
- Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature. (Q39457760) (← links)
- Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer (Q39550407) (← links)
- Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria. (Q39863407) (← links)
- Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer (Q40069065) (← links)
- Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes. (Q40341215) (← links)
- Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients (Q40410396) (← links)
- EORTC Risk Model to Predict Progression in Patients With Non-Muscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice? (Q40457621) (← links)
- Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging. (Q40458086) (← links)
- Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy (Q41284368) (← links)
- Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for pati (Q41431943) (← links)
- Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. (Q41599456) (← links)
- Hyperhomocysteinemia as an Early Predictor of Erectile Dysfunction: International Index of Erectile Function (IIEF) and Penile Doppler Ultrasound Correlation With Plasma Levels of Homocysteine (Q42039893) (← links)
- Anterior prostatic tumours are difficult to diagnose without MRI (Q42150549) (← links)